Lulilok S Cream is a topical dermatological formulation containing Salicylic Acid (3% w/w) and Luliconazole (1% w/w), designed for the effective management of various fungal and keratotic skin conditions. Salicylic Acid acts as a keratolytic agent, promoting the exfoliation of the stratum corneum by softening and loosening keratin, thereby facilitating the removal of scales and enhancing the penetration of the antifungal component. Luliconazole, a broad-spectrum imidazole antifungal, exhibits potent activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to fungal cell death. This combination is particularly beneficial in treating dermatophytosis, tinea infections, and other superficial fungal infections characterized by hyperkeratosis and scaling. Lulilok S Cream is applied topically to the affected area once or twice daily as directed by a healthcare professional. It is generally well tolerated, with minimal local adverse effects such as mild irritation or erythema. Patients should avoid contact with eyes and mucous membranes and discontinue use if hypersensitivity reactions occur. The synergistic action of Salicylic Acid and Luliconazole in Lulilok S Cream provides an effective therapeutic option for managing resistant and complicated fungal skin infections.